Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Prediction of Drug Clearance in Children.

Foissac F, Bouazza N, Valade E, De Sousa Mendes M, Fauchet F, Benaboud S, Hirt D, Tréluyer JM, Urien S.

J Clin Pharmacol. 2015 Feb 26. doi: 10.1002/jcph.488. [Epub ahead of print]

PMID:
25721251
2.

Favipiravir for children with Ebola.

Bouazza N, Treluyer JM, Foissac F, Mentré F, Taburet AM, Guedj J, Anglaret X, de Lamballerie X, Keïta S, Malvy D, Frange P.

Lancet. 2015 Feb 14;385(9968):603-4. doi: 10.1016/S0140-6736(15)60232-X. No abstract available.

PMID:
25706078
3.

Detection of Significant Prostate Cancer with Magnetic Resonance Targeted Biopsies-Should Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Biopsies Alone be a Standard of Care?

Delongchamps NB, Lefèvre A, Bouazza N, Beuvon F, Legman P, Cornud F.

J Urol. 2015 Apr;193(4):1198-204. doi: 10.1016/j.juro.2014.11.002. Epub 2014 Nov 11.

PMID:
25451824
4.

Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations.

Bouazza N, Foissac F, Fauchet F, Burger D, Kiechel JR, Treluyer JM, Capparelli EV, Lallemant M, Urien S.

Antivir Ther. 2014 Oct 3. doi: 10.3851/IMP2876. [Epub ahead of print]

PMID:
25279808
5.

Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?

Fauchet F, Treluyer JM, Valade E, Benaboud S, Pannier E, Firtion G, Foissac F, Bouazza N, Urien S, Hirt D.

Br J Clin Pharmacol. 2014 Dec;78(6):1387-96. doi: 10.1111/bcp.12459.

PMID:
25040510
6.

Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.

Valade E, Tréluyer JM, Dabis F, Arrivé E, Pannier E, Benaboud S, Fauchet F, Bouazza N, Foissac F, Urien S, Hirt D.

Br J Clin Pharmacol. 2014 Dec;78(6):1378-86. doi: 10.1111/bcp.12457.

PMID:
24995851
7.

Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.

Foissac F, Meyzer C, Frange P, Chappuy H, Benaboud S, Bouazza N, Friedlander G, Souberbielle JC, Urien S, Blanche S, Tréluyer JM.

Br J Clin Pharmacol. 2014 Nov;78(5):1113-21. doi: 10.1111/bcp.12433.

PMID:
24902982
8.

Evaluation of effect of impaired renal function on lamivudine pharmacokinetics.

Bouazza N, Tréluyer JM, Ghosn J, Hirt D, Benaboud S, Foissac F, Viard JP, Urien S.

Br J Clin Pharmacol. 2014 Oct;78(4):847-54. doi: 10.1111/bcp.12407.

PMID:
24750102
9.

Concentration-response model of lopinavir/ritonavir in HIV-1-infected pediatric patients.

Bouazza N, Urien S, Blanche S, Hirt D, Foissac F, Benaboud S, Tréluyer JM, Frange P.

Pediatr Infect Dis J. 2014 Aug;33(8):e213-8. doi: 10.1097/INF.0000000000000298.

PMID:
24509655
10.

Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients.

Valade E, Tréluyer JM, Bouazza N, Ghosn J, Foissac F, Benaboud S, Fauchet F, Viard JP, Urien S, Hirt D.

Antimicrob Agents Chemother. 2014;58(4):2256-61. doi: 10.1128/AAC.02058-13. Epub 2014 Feb 3.

11.

Dental caries and enamelin haplotype.

Chaussain C, Bouazza N, Gasse B, Laffont AG, Opsahl Vital S, Davit-Béal T, Moulis E, Chabadel O, Hennequin M, Courson F, Droz D, Vaysse F, Laboux O, Tassery H, Carel JC, Alcais A, Treluyer JM, Beldjord C, Sire JY.

J Dent Res. 2014 Apr;93(4):360-5. doi: 10.1177/0022034514522060. Epub 2014 Jan 31.

PMID:
24487377
12.

Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?

Cornud F, Khoury G, Bouazza N, Beuvon F, Peyromaure M, Flam T, Zerbib M, Legmann P, Delongchamps NB.

J Urol. 2014 May;191(5):1272-9. doi: 10.1016/j.juro.2013.12.006. Epub 2013 Dec 12.

PMID:
24333516
13.

Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland.

Chappuy H, Keitel K, Gehri M, Tabin R, Robitaille L, Raymond F, Corbeil J, Maspoli V, Bouazza N, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A.

BMC Infect Dis. 2013 Jul 31;13:357. doi: 10.1186/1471-2334-13-357.

14.

Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.

Fauchet F, Treluyer JM, Frange P, Urien S, Foissac F, Bouazza N, Benaboud S, Blanche S, Hirt D.

Antimicrob Agents Chemother. 2013 Oct;57(10):4801-8. doi: 10.1128/AAC.00911-13. Epub 2013 Jul 22.

15.

Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study.

Chappuy H, Bouazza N, Minard-Colin V, Patte C, Brugières L, Landman-Parker J, Auvrignon A, Davous D, Pacquement H, Orbach D, Tréluyer JM, Doz F.

BMJ Open. 2013 May 28;3(5). pii: e002733. doi: 10.1136/bmjopen-2013-002733.

16.

A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients.

Bouazza N, Tréluyer JM, Msellati P, Van de Perre P, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Hirt D, Urien S.

AIDS. 2013 Mar 13;27(5):761-8. doi: 10.1097/QAD.0b013e32835caad1.

PMID:
23719348
17.

Within-host dynamics of the emergence of Tomato yellow leaf curl virus recombinants.

Urbino C, Gutiérrez S, Antolik A, Bouazza N, Doumayrou J, Granier M, Martin DP, Peterschmitt M.

PLoS One. 2013;8(3):e58375. doi: 10.1371/journal.pone.0058375. Epub 2013 Mar 5.

18.

Evaluation of nevirapine dosing recommendations in HIV-infected children.

Foissac F, Bouazza N, Frange P, Blanche S, Faye A, Lachassinne E, Dollfus C, Hirt D, Benaboud S, Treluyer JM, Urien S.

Br J Clin Pharmacol. 2013 Jul;76(1):137-44. doi: 10.1111/bcp.12069.

19.

Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies.

Delongchamps NB, Peyromaure M, Schull A, Beuvon F, Bouazza N, Flam T, Zerbib M, Muradyan N, Legman P, Cornud F.

J Urol. 2013 Feb;189(2):493-9. doi: 10.1016/j.juro.2012.08.195. Epub 2012 Oct 8.

PMID:
22982424
20.

Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Bouazza N, Pestre V, Jullien V, Curis E, Urien S, Salmon D, Tréluyer JM.

Br J Clin Pharmacol. 2012 Dec;74(6):971-7. doi: 10.1111/j.1365-2125.2012.04292.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk